drugset / Trial / NCT01863277
Safety Study of Melatonin in Stroke Patients
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of the study is to evaluate the effect of Melatonin (in a dosage of 14mg daily) for a better clinical outcome in the period three days post stroke.
Timeline
- Start
- 2013-07
- Primary completion
- 2014-04
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Melatonin | Small molecule | 14 mg | — |